Patenting stem cells in Europe: The challenge of multiplicity in European Union law

Show simplified metadata
dc.contributor.authorSándor, Judit
dc.contributor.authorVarjú, Márton
dc.contributor.unitOther
dc.date.available2022-03-29T08:58:38Z
dc.date.issued2012
dc.description.abstractThe recent judgment by the European Court of Justice in Brüstle ended the long-standing controversy concerning the patentability of inventions involving human embryonic stem cells in European patent law as harmonized by the Biotechnology Directive (Directive 98/44/EC). The Court of Justice, in line with EPO practice, confirmed that Article 6 of the Biotechnology Directive excluding the patentability of industrial or commercial uses of human embryos prevents patenting human embryonic stem cells. The judgment is open to criticism on account of its interpretation of the relevant ethical principles laid down in the Biotechnology Directive in an environment characterized by moral pluralism and by a multiplicity of legal fora with jurisdiction to interpret those principles.
dc.identifier.issn0165-0750
dc.identifier.urihttps://hdl.handle.net/20.500.14018/10392
dc.identifier.urlhttps://kluwerlawonline.com/api/Product/CitationPDFURL?file=Journals\COLA\COLA2012037.pdf
dc.language.isoeng
dc.publisherWolters Kluwer
dc.publisher.placeAlphen aan den Rijn
dc.source.epage1037
dc.source.issue3
dc.source.journaltitleCommon Market Law Review
dc.source.spage1007
dc.source.volume49
dc.titlePatenting stem cells in Europe: The challenge of multiplicity in European Union law
dc.typeJournal article
dspace.entity.typePublication
refterms.dateFOA2022-03-29T08:58:38Z
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Sandor-Judit_2012-2.pdf
Size:
199.34 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Other Academic Units